健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Mind Body Program for Fear of Recurrence

赞助:
合作者:
信息的提供 (责任方):
Gloria Y. Yeh,Beth Israel Deaconess Medical Center
October 2, 2018
October 4, 2018
October 4, 2018
August 9, 2017
June 30, 2019   (主要结果测量的最终数据收集日期)
Feasibility[ Time Frame: Through study completion (approximately 5 months) ]
The primary metric for assessing Feasibility will be retention at the initial follow-up assessment. Reasons for ineligibility, refusal, or dropping out will be measured.

Acceptability[ Time Frame: During intervention group sessions (approximately 2 months) ]
The primary metric for assessing Acceptability will be a five-item, investigator developed self-report questionnaire. Following each study session, participants will be asked to rate (1=not at all to 5=very much) the enjoyableness, convenience, helpfulness, relevancy, odds of future use, and overall satisfaction of the session.

与当前相同
  • Fear of Cancer Recurrence[ Time Frame: Baseline, 8 weeks (Post-intervention), 1 month follow-up, 3 months follow-up ]
    Fear of Cancer Recurrence Inventory. Validated self-report measure of fear of cancer recurrence. 42 items across 7 subscales (triggers, severity, psychological distress, coping strategies, functioning impairments, insight, and reassurance). Higher scores indicate more fear of recurrence. Severity subscale score ≥13 indicates clinically-elevated FCR.
 
Mind Body Program for Fear of Recurrence
Mind Body Program for Fear of Recurrence

This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.

Interventional
N/A
分配:
干预模型: Single Group Assignment
干预模型描述:
盲法: Interventional
盲法描述:
主要目的: Other
  • Behavioral: Mind-Body Program for Fear of Recurrence
    An adapted protocol of the Relaxation Response Resiliency Program, a manualized, group-based, multimodal mind body program. Protocol adaptation includes refinement of content and study procedures to target fear of cancer recurrence (FCR) among adult cancer survivors.
  • Experimental: Mind-Body Group Intervention
 
Recruiting
25
与当前相同
April 14, 2020
June 30, 2019   (主要结果测量的最终数据收集日期)
Inclusion Criteria: 1. Patients must have a history of breast, lung, colorectal, hematologic, prostate, melanoma, or gynecological cancer (by medical record and/or self-report) 2. Completion of primary cancer treatment (radiation, surgery, and/or chemotherapy) between 3 to 30 months ago 3. Ages 18 and older (by medical record and/or self-report) Exclusion Criteria: 1. Self-reported inability to speak and write in English 2. Concurrent participation in weekly, group-based psychosocial or mind-body programs 3. Serious mental illness (by medical record and/or self-report) as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year. 4. Inability to travel to necessary study visits 5. No e-mail address to access online assessments
参与研究的性别: All
最小年龄:18 Years ,最大年龄:N/A  
没有
United States
 
No
研究美国FDA监管的药品: No
研究涉及美国FDA监管的设备产品: No
计划分享 IPD: No
Gloria Y. Yeh,Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
:
Beth Israel Deaconess Medical Center
October 2018

ICMJE     国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素
请使用微信扫码报名